AGC
LLY icon

Aspen Grove Capital’s Eli Lilly LLY Stock Holding History

Aspen Grove Capital’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.16M Buy
4,303
+50
+1% +$51.1K 0.74% 27
2026
Q1 		$3.91M Hold
4,253
– – 0.76% 26
2025
Q4 		$4.57M Hold
4,253
– – 0.79% 24
2025
Q3 		$3.25M Sell
4,253
-150
-3% -$112K 0.55% 30
2025
Q2 		$3.43M Buy
4,403
+403
+10% +$313K 0.58% 29
2025
Q1 		$3.3M Buy
4,000
+21
+0.5% +$17.5K 0.64% 26
2024
Q4 		$3.07M Buy
3,979
+4
+0.1% +$3.31K 0.65% 29
2024
Q3 		$3.52M Sell
3,975
-66
-2% -$59.3K 0.78% 22
2024
Q2 		$3.66M Buy
4,041
+64
+2% +$51.2K 0.86% 21
2024
Q1 		$3.09M Buy
3,977
+76
+2% +$54.1K 0.88% 22
2023
Q4 		$2.26M Buy
3,901
+69
+2% +$40.3K 0.69% 31
2023
Q3 		$2.06M Buy
3,832
+2,267
+145% +$1.17M 0.76% 29
2023
Q2 		$734K Buy
1,565
+520
+50% +$218K 0.24% 83
2023
Q1 		$359K Buy
1,045
+152
+17% +$51.3K 0.16% 104
2022
Q4 		$327K Buy
+893
New +$317K 0.15% 105

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Aspen Grove Capital's LLY Position: Q2 2026 in Review

Aspen Grove Capital increased its Eli Lilly (LLY) stake by 1.2% in Q2 2026, buying an estimated $51.1K and bringing the position to 4,303 shares worth $5.16M. The position accounts for 0.74% of the portfolio, ranked #27.

Aspen Grove Capital first reported a position in LLY in Q4 2022 and has held it in 15 quarters since. 4,635 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Aspen Grove Capital held 4,303 shares of Eli Lilly worth $5.16M as of Q2 2026.
  • Aspen Grove Capital bought 50 Eli Lilly shares in Q2 2026, an estimated $51.1K.
  • Eli Lilly made up 0.74% of Aspen Grove Capital's portfolio in Q2 2026, its #27 holding.
  • Aspen Grove Capital first reported a position in Eli Lilly in Q4 2022 and has held it in 15 quarters since.
  • 4,635 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Aspen Grove Capital's 13F filing for Q2 2026, filed 14 Aug 2026.